Behr, Carina M. http://orcid.org/0000-0001-6094-807X
Oude Wolcherink, Martijn J.
IJzerman, Maarten J.
Vliegenthart, Rozemarijn
Koffijberg, Hendrik
Funding for this research was provided by:
Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie (10-10400-98-008)
Article History
Accepted: 27 December 2022
First Online: 20 January 2023
Declarations
:
: No consent was obtained, as there were no participants in this study.
: No human research participants were included in this study; therefore, no consent to publish was obtained.
: The data gathered and analysed in this study are included in the article as well as the supplementary materials.
: This study is funded by The Netherlands Organisation for Health Research and Development (ZonMw) (IMDI program, dossier number: 10-10400-98-008, B3Care project). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The University of Twente funded the open access publication of this article.
: R. Vliegenthart is supported by an institutional research grant from Siemens Healthineers and reports speaker’s fees from Siemens Healthineers and Bayer. In addition, M.J. IJzerman has held advisory board roles with respect to Illumina, and his institution (University of Melbourne) receives unrestricted research funding from Illumina. H. Koffijberg, C.M. Behr and M.J. Oude Wolcherink declare that they have no conflict of interest.
: CMB conducted the systematic review and wrote the first draft of the paper. MJOW performed a sample of the abstract screening and the full-text screening as the second reviewer. HK acted as third reviewer by resolving conflicts regarding reviewing after both screening rounds. MJI, RV and HK advised on the goal and implementation of the review and drawing conclusions from the results. All authors reviewed and contributed to the manuscript.
: Not applicable.
: Not applicable.